26,793 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Genentech Acquisitions

Genentech has acquired 6 companies and its latest acquisition was Regor Pharmaceuticals's Next-Generation CDK Inhibitors on Sep 2024

Unlock 3 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Regor Pharmaceuticals's Next-Generation CDK Inhibitors

Sep 2024

Source »
$850M
-
Jecure Therapeutics Inc.

Nov 2018

Source »
undisclosed
Jecure discovers and develops small-molecule therapeutics for the treatment of non-alcoholic steatohepatitis and liver fibrosis.
Seragon Pharmaceuticals, Inc.

Jul 2014

Source »
$725M
Seragon Pharmaceuticals is a research-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer.
Arrayit Corporation

Sep 2013

Source »
undisclosed
Arrayit develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function.

-

Tanox

Aug 2007

Source »
$919M
-

Frequently Asked Questions about Genentech

  1. What companies did Genentech acquire?

    Companies acquired by Genentech include , Jecure and Seragon Pharmaceuticals

  2. How many acquisitions does Genentech have?

    Genentech has acquired 6 companies including , Jecure and Seragon Pharmaceuticals.

  1. How many acquisitions did Genentech make in 2024?

    In 2024 Genentech acquired 1 companies including undefined.